Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1
    UID:
    b3kat_BV047470550
    Format: 350 Seiten
    Edition: Deutsche Erstausgabe
    ISBN: 9783498002770
    Uniform Title: The vaccine
    Note: Hier auch später erschienene, unveränderte Nachdrucke , Uğur Şahin und Özlem Türeci, Wissenschaftler und Mitgründer von BioNTech, haben den weltweit ersten zugelassenen Covid-19-Impfstoff entwickelt - und damit Medizingeschichte geschrieben. Der Financial Times-Journalist Joe Miller hat die beiden seit März 2020 begleitet und erzählt ihre Geschichte von den ersten Stunden des Kampfes gegen Covid-19 bis zur Zulassung des Impfstoffs. Miller beschreibt, wie Şahin und Türeci mit einem kleinen internationalen Team von Spezialisten in kürzester Zeit 20 Impfstoff-Kandidaten hergestellt haben, wie sie große Pharmaunternehmen überzeugt haben, ihre Arbeit zu unterstützen, wie sie Verhandlungen mit der EU und der US-Regierung führten und wie sie es mit BioNTech als kleinem Mainzer Unternehmen schafften, mehr als zwei Milliarden Impfdosen zu produzieren. Neben Şahin und Türeci hat Miller mit über 50 Wissenschaftlern, Politikern und Mitarbeitern von BioNTech über diese einmalige und unvergessliche Zeit gesprochen: über ihre Erfahrungen, ihre Herausforderungen und den Triumph. Das Buch zeigt, wie die beiden Wissenschaftler auf 30 Jahre Forschung an der neuartigen mRNA-Technologie aufbauen konnten, um einen Ausweg aus der Corona-Pandemie zu finden. Und es teilt die Vision der Mediziner, mit der mRNA-Technologie Therapien gegen viele andere Krankheiten wie Krebs, HIV oder Tuberkulose zu finden
    Additional Edition: Erscheint auch als Online-Ausgabe ISBN 978-3-644-01193-9
    Language: German
    Subjects: Economics , Medicine
    RVK:
    RVK:
    Keywords: BioNTech SE ; Impfstoff ; Entwicklung ; COVID-19 ; Geschichte ; BioNTech SE ; Messenger-RNS ; Coronaviren ; Impfstoff ; COVID-19 ; COVID-19 ; Pandemie ; Impfstoff ; Arzneimittelentwicklung ; BioNTech SE ; Geschichte 2020-2021
    Author information: Sahin, Ugur 1965-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    b3kat_BV048298286
    Format: 350 Seiten
    Edition: 2. Auflage, Deutsche Erstausgabe
    ISBN: 9783498002770
    Uniform Title: The vaccine
    Additional Edition: Erscheint auch als Online-Ausgabe ISBN 978-3-644-01193-9
    Language: German
    Subjects: Economics , Medicine
    RVK:
    RVK:
    RVK:
    Keywords: BioNTech SE ; Impfstoff ; Entwicklung ; COVID-19 ; Geschichte ; BioNTech SE ; Messenger-RNS ; Coronaviren ; Impfstoff ; COVID-19 ; COVID-19 ; Pandemie ; Impfstoff ; Arzneimittelentwicklung ; BioNTech SE ; Geschichte 2020-2021
    Author information: Sahin, Ugur 1965-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    St. Martin's Publishing Group
    UID:
    kobvindex_ZLB34872282
    ISBN: 9781250280374
    Content: " Winners of the Paul Ehrlich PrizeThe dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19. Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA,they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first,but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world's first clinically approved inoculation for the coronavirus. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age,it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time. Written by Joe Miller8212 the Financial Times' Frankfurt correspondent who covered BioNTech's COVID-19 project in real time8212 with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic. "
    Content: Biographisches: " Joe Miller is the Frankfurt correspondent for Financial Times . He previously reported for BBC News in London, New York, Delhi, and Berlin." Rezension(2): "Angela Merkel, former Chancellor of Germany, Süddeutsche Zeitung : I have now read the book by Joe Miller about the development of the vaccine at BioNTech. Ugur Sahin had already understood the scale of the pandemic on 24 January. I wasn't that quick." Rezension(3): " The Times (London):Özlem Türeci and Ugur Sahin are rapidly becoming the most celebrated marriage in science since Marie and Pierre Curie discovered radioactivity." Rezension(4): " Financial Times (FT People of the Year):They are the symbol of a remarkable scientific and business success story." Rezension(5): " Bloomberg :The story of their quest to use a novel scientific method to defeat that disease, as well as cancer and others, would suffice to make them heroes of our time." Rezension(6): "〈a href=http://www.publishersweekly.com target=blank〉〈img src=https://images.contentreserve.com/pw_logo.png alt=Publisher's Weekly border=0 /〉〈/a〉: January 10, 2022 Financial Times correspondent Miller delivers a fascinating survey of the remarkable achievements of doctors T252" Rezension(7): "〈a href=http://www.kirkusreviews.com target=blank〉〈img src=https://images.contentreserve.com/kirkus_logo.png alt=Kirkus border=0 /〉〈/a〉: January 15, 2022 The story of the development of the first effective Covid-19 vaccine. Readers of Gregory Zuckerman's excellent A Shot To Save the World learned about the complex mix of unparalleled science, rampant ambition, and fierce competition that led to the creation of a viable vaccine. Miller, the Frankfurt correspondent for the Financial Times who reported on the scientific race, tells a different but equally gripping story that emphasizes aggressive German startup BioNTech, founded by the brilliant husband-and-wife team of T�reci and 350"
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    b3kat_BV009891094
    Format: 80 S. , graph. Darst.
    Note: Köln, Univ., Diss., 1993
    Language: German
    Keywords: Hochschulschrift
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    UID:
    kobvindex_SLB965645
    Format: 350 Seiten , 22 cm
    Edition: Deutsche Erstausgabe
    ISBN: 9783498002770
    Content: Der Autor Joe Miller begleitet die Wissenschaftler und Mitbegründer der Firma Biontech, Ugur Sahin und Özlem Türeci, seit März 2020 auf dem Weg zur Entwicklung des weltweit ersten zugelassenen Impfstoffs gegen Covid-19.
    Language: German
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    UID:
    kobvindex_VBRD-i97834980027700352
    Format: 352 Seiten
    Edition: 2. Auflage
    ISBN: 9783498002770
    Uniform Title: The Vaccine
    Language: German
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    UID:
    kobvindex_ZLB34926526
    Edition: Unabridged
    ISBN: 9781250846839
    Content: " The dramatic story of the married scientists who founded BioNTech and developed the first vaccine against the COVID-19 pandemic. Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA,they believed it could be harnessed to turn the human body into its own pharmacy. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first,but by the time Sars-Cov-2 was discovered in Wuhan, BioNTech was prepared to deploy cutting edge technology and create the world's first approved inoculation for the coronavirus. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age,it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and manage to provide more than two billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time. Written by Joe Miller8212 the Financial Times' Frankfurt correspondent who covered BioNTech's COVID-19 project in real time8212 with contributions from Sahin and Türeci, as well as interviews with more than 50 scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average listener and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic. A Macmillan Audio production from St. Martin's Press "
    Content: Biographisches: " Joe Miller is the Frankfurt correspondent for Financial Times . He previously reported for BBC News in London, New York, Delhi, and Berlin."
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    UID:
    kobvindex_SBC1260852
    Format: 350 Seiten , 22 cm
    Edition: Deutsche Erstausgabe
    ISBN: 9783498002770
    Uniform Title: The Vaccine
    Content: Uğur Şahin und Özlem Türeci, Wissenschaftler und Mitgründer von BioNTech, haben den weltweit ersten zugelassenen Covid-19-Impfstoff entwickelt - und damit Medizingeschichte geschrieben. Der Financial Times-Journalist Joe Miller hat die beiden seit März 2020 begleitet und erzählt ihre Geschichte von den ersten Stunden des Kampfes gegen Covid-19 bis zur Zulassung des Impfstoffs. Miller beschreibt, wie Sahin und Türeci mit einem kleinen internationalen Team von Spezialisten in kürzester Zeit 20 Impfstoff-Kandidaten hergestellt haben, wie sie große Pharmaunternehmen überzeugt haben, ihre Arbeit zu unterstützen, wie sie Verhandlungen mit der EU und der US-Regierung führten und wie sie es mit BioNTech als kleinem Mainzer Unternehmen schafften, mehr als zwei Milliarden Impfdosen zu produzieren. Neben Sahin und Türeci hat Miller mit über 50 Wissenschaftlern, Politikern und Mitarbeitern von BioNTech über diese einmalige und unvergessliche Zeit gesprochen: über ihre Erfahrungen, ihre Herausforderungen und den Triumph. Das Buch zeigt, wie die beiden Wissenschaftler auf 30 Jahre Forschung an der neuartigen mRNA-Technologie aufbauen konnten, um einen Ausweg aus der Corona-Pandemie zu finden. Und es teilt die Vision der Mediziner, mit der mRNA-Technologie Therapien gegen viele andere Krankheiten wie Krebs, HIV oder Tuberkulose zu finden. Eine beeindruckende Geschichte zweier außergewöhnlicher Menschen.
    Note: Deutsch
    Language: German
    Keywords: Bericht
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    UID:
    kobvindex_ZLB34977439
    Format: 292 pages
    Edition: First publishing
    ISBN: 9781802791242
    Content: Winners of the Paul Ehrlich Prize. The dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19. Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA,they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first,but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world's first clinically approved inoculation for the coronavirus. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age,it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time. Written by Joe Miller8212 the Financial Times' Frankfurt correspondent who covered BioNTech's COVID-19 project in real time8212 with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic. "
    Language: English
    Keywords: COVID-19 ; Pandemie ; Impfstoff ; Arzneimittelentwicklung
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    UID:
    kobvindex_ZLB34711444
    Format: 350 Seiten , 21.5 cm x 14 cm
    Edition: Deutsche Erstausgabe
    ISBN: 9783498002770 , 3498002775
    Content: Ugur Sahin und Özlem Türeci, Wissenschaftler und Mitgründer von BioNTech, haben den weltweit ersten zugelassenen Covid-19-Impfstoff entwickelt - und damit Medizingeschichte geschrieben. Der Financial Times-Journalist Joe Miller hat die beiden seit März 2020 begleitet und erzählt ihre Geschichte von den ersten Stunden des Kampfes gegen Covid-19 bis zur Zulassung des Impfstoffs. Miller beschreibt, wie Sahin und Türeci mit einem kleinen internationalen Team von Spezialisten in kürzester Zeit 20 Impfstoff-Kandidaten hergestellt haben, wie sie große Pharmaunternehmen überzeugt haben, ihre Arbeit zu unterstützen, wie sie Verhandlungen mit der EU und der US-Regierung führten und wie sie es mit BioNTech als kleinem Mainzer Unternehmen schafften, mehr als zwei Milliarden Impfdosen zu produzieren. Neben Sahin und Türeci hat Miller mit über 50 Wissenschaftlern, Politikern und Mitarbeitern von BioNTech über diese einmalige und unvergessliche Zeit gesprochen: über ihre Erfahrungen, ihre Herausforderungen und den Triumph. Das Buch zeigt, wie die beiden Wissenschaftler auf 30 Jahre Forschung an der neuartigen mRNA-Technologie aufbauen konnten, um einen Ausweg aus der Corona-Pandemie zu finden. Und es teilt die Vision der Mediziner, mit der mRNA-Technologie Therapien gegen viele andere Krankheiten wie Krebs, HIV oder Tuberkulose zu finden. Eine beeindruckende Geschichte zweier außergewöhnlicher Menschen.
    Content: Aktuelle Zeitgeschichte zur Firma BioNTech: Gründung, Grundlagenforschung und Impfstoffentwicklung. Viele Einblicke in das Leben des Forscherpaares Türeci und Sahin, und den langen, oft steinigen Weg zum Erfolg auf einem neuen Forschungsgebiet, der Entwicklung von mRNA-Impfstoff.
    Language: German
    Keywords: COVID-19 ; Pandemie ; Impfstoff ; Arzneimittelentwicklung
    Author information: Liebl, Elisabeth
    Author information: Zeltner-Shane, Henriette
    Author information: Kober, Hainer
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages